Keyuan

Shandong Keyuan Pharmaceutical Co., Ltd. is a prominent Chinese pharmaceutical enterprise focused on the development and large-scale production of chemical active pharmaceutical ingredients (APIs) and finished dosage forms. Established in 2004 and headquartered in Jinan, the company has built a global reputation as a leading supplier of Metformin Hydrochloride, a cornerstone treatment for type 2 diabetes. Beyond endocrinology, Keyuan’s portfolio encompasses cardiovascular agents, anesthetics, and psychotropic drugs, supported by advanced GMP-certified manufacturing facilities. The company is publicly traded on the Shenzhen Stock Exchange and continues to expand its international footprint through strategic exports and high-quality chemical synthesis.